Publications in collaboration with researchers from Centro de Investigación Cooperativa en Biotecnología (17)

2022

  1. Epigenetic Mechanisms Influencing Therapeutic Response in Breast Cancer

    Frontiers in Oncology, Vol. 12

  2. PI3K-regulated Glycine N-methyltransferase is required for the development of prostate cancer

    Oncogenesis, Vol. 11, Núm. 1

  3. The Oncogenic PI3K-Induced Transcriptomic Landscape Reveals Key Functions in Splicing and Gene Expression Regulation

    Cancer Research, Vol. 82, Núm. 12, pp. 2269-2280

2021

  1. FOXA1 mutations influence the therapeutic response of breast cancer by altering chromatin state

    Molecular and Cellular Oncology

2020

  1. Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer

    The Journal of experimental medicine, Vol. 217, Núm. 6

  2. Targeting PML in triple negative breast cancer elicits growth suppression and senescence

    Cell Death and Differentiation, Vol. 27, Núm. 4, pp. 1186-1199

2018

  1. Low-dose statin treatment increases prostate cancer aggressiveness

    Oncotarget, Vol. 9, Núm. 2, pp. 1494-1504

  2. Oil for the cancer engine: The cross-talk between oncogenic signaling and polyamine metabolism

    Science Advances, Vol. 4, Núm. 1

  3. PPARd elicits ligand-independent repression of trefoil factor family to limit prostate cancer growth

    Cancer Research, Vol. 78, Núm. 2, pp. 399-409

2017

  1. MTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer

    Nature, Vol. 547, Núm. 7661, pp. 109-113

2016

  1. HEY1 functions are regulated by its phosphorylation at Ser-68

    Bioscience Reports, Vol. 36, Núm. 3

  2. Pharmacological inhibition of fatty-acid oxidation synergistically enhances the effect of l-asparaginase in childhood ALL cells

    Leukemia, Vol. 30, Núm. 1, pp. 209-218

  3. Stratification and therapeutic potential of PML in metastatic breast cancer

    Nature Communications, Vol. 7

  4. The metabolic co-regulator PGC1α suppresses prostate cancer metastasis

    Nature Cell Biology, Vol. 18, Núm. 6, pp. 645-656

  5. Transcriptomic profiling of urine extracellular vesicles reveals alterations of CDH3 in prostate cancer

    Oncotarget, Vol. 7, Núm. 6, pp. 6835-6846

2015

  1. Methodological aspects of the molecular and histological study of prostate cancer: Focus on PTEN

    Methods, Vol. 77, pp. 25-30

  2. PTEN mediates Notch-dependent stalk cell arrest in angiogenesis

    Nature Communications, Vol. 6